ArticleThe Journal of membrane biology2026
Mechanistic Insights into Human Defensin Antimicrobial Activity from Membrane Simulations.
Article in The Journal of membrane biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Defensins function as critical effectors of innate immunity, displaying broad-spectrum antimicrobial activity against bacteria, fungi, and viruses. While experimental studies have extensively characterized these peptides, the molecular mechanisms governing their membrane interactions remain poorly understood. This investigation employed comprehensive molecular dynamics simulations to analyze six defensins (human and rabbit α-defensins HNP1, HNP3, rabbit NP4 and human β-defensins HBD1, HBD2, HBD3) using the IMM1 implicit membrane model for studying interactions with anionic bacterial membranes. Both monomeric and dimeric forms were examined to elucidate oligomerization effects on membrane binding and penetration mechanisms. Transfer energy calculations revealed distinct binding patterns and orientations among different defensin subtypes, with β-defensins demonstrating superior membrane affinity compared to α-defensins. HBD3 exhibited the most favorable membrane interactions, correlating with its exceptional antimicrobial potency. Binding orientation analysis demonstrated that defensins adopt specific membrane-bound configurations that optimize electrostatic interactions with anionic membrane surfaces while strategically positioning hydrophobic regions for effective membrane insertion. These findings provide molecular level insights into defensin selectivity mechanisms for bacterial membranes and establish a foundation for defensin-based therapeutic development. The results validate that computational approaches effectively complement experimental studies in elucidating complex antimicrobial peptide mechanisms. This modeling framework supports rational design of next generation defensin therapeutics with optimized antimicrobial activity and pathogen selectivity.
Indexed as
Identifiers
41779197What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.